Multiple Myeloma Research Consortium (MMRC) Genomics Initiative provides first in depth look at multiple myeloma genome
Multiple Myeloma Research Consortium (MMRC) initiates phase IB/II clinical trial of Treanda in combination with Revlimid and Dexamethasone in patients with relapsed multiple myeloma
No comments:
Post a Comment